| Serial Number | 88598286 |
| Word Mark | CELLREGEN |
| Filing Date | Thursday, August 29, 2019 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, October 25, 2021 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, January 26, 2021 |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Description of Mark | The mark consists of The word "CellReGen" with the letters "C" "R" and "G" all capitalized, with the "R" having a gapped corner on the top left, all to the left of a square that has gapped corners on the top left and bottom right. |
| Goods and Services | Biological preparations for others, namely, human cells and tissue for scientific and research use; Cells and biological tissue, namely, human tissue, stem cells, bone marrow, amniotic fluid and blood, for scientific research and use in cellular therapies; biological preparations for others, namely, human cells and tissue, for use in the research of treatment of degenerative diseases, wound healing, and cell therapy |
| Goods and Services | Biological and chemical products for use by clinicians in regenerative medicine for medical purposes, namely, cellular healing therapies and regenerative medicine |
| Goods and Services | Business consulting and industry collaboration in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials, applications for drug approval and product development; providing product commercialization assistance in the field of cellular therapy and regenerative medicine; commercialization services in the field of cellular therapy and regenerative medicine |
| Goods and Services | Contract manufacturing, namely, manufacture of cellular therapies and regenerative medicines; conducting manufacturing support, namely, development of operating procedures and batch records, cell expansion, master and working cell bank production and clinical trials in the field of cellular therapy and regenerative medicine |
| Goods and Services | Academic support, namely, providing clinical programs, academic conferences, training, mentoring and fellowships in the field of clinical trials, technology transfer, product development, optimization, manufacturing and commercialization; educational services in the field of cellular therapy and regenerative medicine |
| Goods and Services | Conducting clinical trials and research for others in the field of cellular therapy and regenerative medicine; providing medical and scientific research information in the field of clinical trials for cellular therapy and regenerative medicine; Product research and development; Product development consultation; Product research and development services for others in the field of cellular therapy and regenerative medicine; scientific development in the field of stem cells and regenerative medicine; scientific research, discovery, technology transfer, process development and clinical trials in the field of cellular therapy and regenerative medicine |
| Goods and Services | Medical services in the field of cell-based therapies, including the use of biological cells and tissue in the delivery of cell-based therapies and regenerative medicine; Cell therapy services for the treatment of degenerative diseases, wounds, hematologic diseases, hematologic disorders and immuno-therapy; providing consultancy and information relating to these cell therapies for medical purposes; administration of cell therapies for the treatment of disorders, diseases, and injuries; medical services, namely, isolation of regenerative cells relating to cell therapy services, stem cell collection, processing, phenotypic characterization, infusion and storage for medical and scientific purposes; providing medical therapies, namely, stem cell therapies and therapies for regeneration of human tissues and cells; providing educational medical information about cellular therapy and regenerative medicines |
| Pseudo Mark | CELL REGEN |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, September 11, 2019 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, September 11, 2019 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, September 11, 2019 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, September 11, 2019 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 041 - Education; providing of training; entertainment; sporting and cultural activities. |
| US Class Codes | 100, 101, 107 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, September 11, 2019 |
| Primary Code | 041 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, September 11, 2019 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, September 11, 2019 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | University of Utah Research Foundation |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Salt Lake City, UT 84108 |
| Party Name | University of Utah Research Foundation |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Salt Lake City, UT 84108 |
| Event Date | Event Description |
| Monday, October 25, 2021 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, October 25, 2021 | ABANDONMENT - NO USE STATEMENT FILED |
| Tuesday, March 23, 2021 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, January 26, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, January 26, 2021 | PUBLISHED FOR OPPOSITION |
| Wednesday, January 6, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, December 17, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, December 16, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, December 15, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, December 15, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, June 24, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, June 24, 2020 | NON-FINAL ACTION E-MAILED |
| Wednesday, June 24, 2020 | NON-FINAL ACTION WRITTEN |
| Thursday, June 4, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, June 4, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, June 4, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, December 4, 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, December 4, 2019 | NON-FINAL ACTION E-MAILED |
| Wednesday, December 4, 2019 | NON-FINAL ACTION WRITTEN |
| Monday, December 2, 2019 | ASSIGNED TO EXAMINER |
| Thursday, September 12, 2019 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Wednesday, September 11, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Monday, September 2, 2019 | NEW APPLICATION ENTERED IN TRAM |